Navigation Links
Vanda Pharmaceuticals to Participate in Stifel Nicolaus Global Healthcare Conference and Jefferies Fall 2011 Mid-Atlantic Corporate Access Day
Date:8/31/2011

ROCKVILLE, Md., Aug. 31, 2011 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced that Mihael H. Polymeropoulos, M.D., Vanda President and CEO will deliver a corporate presentation at the Stifel Nicolaus Global Healthcare Conference in Boston, MA on Thursday, September 8, 2011 at 4:25 pm Eastern Time.  

Dr. Polymeropoulos' presentation at the Stifel Nicolaus Global Healthcare Conference will be available live on Vanda's corporate website, where it also will be archived for 30 days.  To access the presentation, log on to http://www.vandapharma.com and click on the Presentations option in the Investor Relations section. Please connect to the website several minutes prior to the start of the live presentation.

On Friday, September 9, 2011, members of the Vanda executive management team will participate in the Jefferies Fall 2011 Mid-Atlantic Corporate Access Day held in Baltimore, MD.    

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com.

Company Contact:
Cristina Murphy
Communications Manager
Vanda Pharmaceuticals Inc.
(240) 599-4500
cristina.murphy@vandapharma.com


'/>"/>
SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Vanda Pharmaceuticals Reports Second Quarter 2011 Results
2. Vanda Pharmaceuticals to Announce Second Quarter 2011 Financial Results on August 4, 2011
3. Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Probiomed S.A. de C.V. for Commercialization of Fanapt™ in Mexico
4. Vanda Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
5. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
6. Vanda Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 5, 2011
7. Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt®
8. Vanda Pharmaceuticals to Evaluate Tasimelteon in Major Depression
9. Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon
10. Vanda Pharmaceuticals Files Shelf Registration Statement
11. Vanda Pharmaceuticals Appoints Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 3, 2015 Today, the world,s ... As markets become ever more transparent, the importance of ... recognised long ago. Its maxim of "innovation brings progress ... and digitisation. The company has long been ... of the art" technology and modern approach, while also ...
(Date:6/2/2015)... 2, 2015  Endo International plc (NASDAQ: ENDP ... that it has commenced an underwritten public offering of ... shares in the offering are to be sold by ... to the underwriters of the Offering an option, exercisable ... of the final prospectus supplement, to purchase an additional ...
(Date:6/2/2015)...  MGC Diagnostics Corporation (NASDAQ: MGCD ), ... results for the second quarter ended April 30, ... equipment, supplies and accessories revenues, compared to the ... During the quarter, competitive account conversions totaled 12 ... accounts, or $850,000 in revenue for the same ...
Breaking Medicine Technology:Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares 2Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares 3Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares 4MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 2MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 3MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 4MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 5MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 6MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 7MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 8MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 9MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 10MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 11MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 12MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 13MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 14
... 2007 - Lux Biosciences,Inc., a privately held biotechnology ... today that the company's,next-generation calcineurin inhibitor, LX211, is ... Research in Vision and,Ophthalmology (ARVO) annual meeting, being ... an oral presentation being given on May 5 ...
... at 59th American Academy of Neurology Annual Meeting, ... /PRNewswire/ --,PTC Therapeutics, Inc. (PTC), a biopharmaceutical company ... targeting,post-transcriptional control processes, today announced positive,interim data from ... patients,with Duchenne muscular dystrophy (DMD) due to a ...
Cached Medicine Technology:Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 2Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 3Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 4PTC Therapeutics Announces Additional Positive Interim Phase 2,Results of PTC124 in Duchenne Muscular Dystrophy 2PTC Therapeutics Announces Additional Positive Interim Phase 2,Results of PTC124 in Duchenne Muscular Dystrophy 3PTC Therapeutics Announces Additional Positive Interim Phase 2,Results of PTC124 in Duchenne Muscular Dystrophy 4PTC Therapeutics Announces Additional Positive Interim Phase 2,Results of PTC124 in Duchenne Muscular Dystrophy 5
(Date:6/3/2015)... 03, 2015 evigilo, a world ... solutions, reported of its "behind-the-scenes" involvement in heroic, ... months. Since March this year, an unusual and ... the South-American country, putting millions in danger. , ... into the atmosphere. "evigilo's technology, adopted by the ...
(Date:6/2/2015)... San Marcos, CA (PRWEB) June 02, 2015 ... a summer special coupon for the months June-September, 2015 along ... wisdom teeth extractions for limited time only. , “Sometimes wisdom ... the soft tissue or jawbone. They can also only partially ... gum tissue. Removal and recovery is easier in young people, ...
(Date:6/2/2015)... June 02, 2015 Concorde Career Colleges, ... President and COO. Bell will manage day-to-day operations for ... looking forward to the opportunity to help our Concorde ... said. “I joined Concorde in part due to reports ... highlighted Concorde colleges in Memphis and Portland.” , Bell ...
(Date:6/2/2015)... Alexandria, VA (PRWEB) June 02, 2015 ... Contact: Erin Wallace, 571-319-9594 (cell) , Email: ewallace(at)mentalhealthamerica(dot)net ... Details of New Mental Health Legislation at MHA ... (PA-18) , What: Rep. Murphy to address the ... details for the long-awaited updated version of the ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 On Wednesday, May ... Supercharged Mustang to a top speed of 207.9 mph. ... 2015 Mustang to break the 200 mph mark. Jay ... filming an upcoming episode of Jay Leno’s Garage, which will ... made on the 8.5 mile high speed oval at the ...
Breaking Medicine News(10 mins):Health News:Thousands of Lives Saved, Millions Protected in Chile 2Health News:$100 Off Coupon for Wisdom Teeth Extractions Offered at Allred Dental 2Health News:Concorde Career Colleges Announces New President and COO 2Health News:Congressman Tim Murphy to Unveil Details of New Mental Health Legislation at MHA Annual Conference Thursday 2Health News:774 HP Hennessey Mustang Tested to 207.9 mph 2
... usually reserved,for lighthearted fun and entertainment, the hallways ... kind of gathering Monday, as child-health,and education experts ... trends in Jordan. Her Majesty Queen Rania Al ... Jordan there, bringing some,welcomed news about the Kingdom,s ...
... estimates 750,000, mostly males, are hooked , , MONDAY, May ... and young adults are problem gamblers according to researchers ... , Problem gambling is defined as gambling associated ... more than you intended or stealing money to gamble. ...
... has targeted an,expansion of its human health and performance ... commercial customers based on the success the,company has had ... other,advanced human support services to the space program., ... human performance and engineering services with an emphasis on,risk ...
... All Natural 100% Juice Superfood Smoothie Line has ,Lifeguard(TM) ... ... Sun Shower(TM) is proud to,introduce a new line of all ... Shower(TM) with the added nutritional,benefits of "Lifeguard(TM) Protection," a fortification package ...
... expansion of serialization initiatives, CRANBURY, N.J., ... Packaging Execution Systems (PES) for the pharmaceutical,industry, ... its sales, central engineering and professional services,teams. ... these areas to support,rapid worldwide deployments; specifically, ...
... Pandemic Influenza Initiatives Also,on the Agenda, WASHINGTON, ... Services (HHS) Secretary Mike Leavitt is visiting the ... efforts to improve the,safety of products on which ... The week-long trip to Beijing and Shanghai includes ...
Cached Medicine News:Health News:Queen Rania Launches Situation Analysis of Children in Jordan Highlighting Jordan's Progress in Improving Quality of Life; 6 Ministers Commit to Further Improving Results 2Health News:Queen Rania Launches Situation Analysis of Children in Jordan Highlighting Jordan's Progress in Improving Quality of Life; 6 Ministers Commit to Further Improving Results 3Health News:Queen Rania Launches Situation Analysis of Children in Jordan Highlighting Jordan's Progress in Improving Quality of Life; 6 Ministers Commit to Further Improving Results 4Health News:Problem Gambling Common Among Young Adults 2Health News:Wyle Targets New Customers for Expanded Human Health and Performance Capabilities and Services 2Health News:New Sun Shower(TM) Superfood Smoothies 2Health News:New Sun Shower(TM) Superfood Smoothies 3Health News:Systech Augments Key Departments to Drive Operational Excellence and International Support 2Health News:Systech Augments Key Departments to Drive Operational Excellence and International Support 3Health News:Secretary Leavitt Travels to the People's Republic of China to Check Up on Efforts to Improve Product Safety 2
The QuickVue Advance® G. vaginalis test is an enzyme activity test for use in the detection of Gardnerella vaginalis Proline IminoPeptidase(PIP) activity in vaginal fluid specimens from women su...
The Osom® Bvblue Test detects elevated vaginal fluid sialidase activity, an enzyme produced by bacterial pathogens associated with Bacterial Vaginosis including Gardnerella, Bacteroides, Prevote...
Nitinol Flat Wire Basket...
1.5 Fr Nitinol Tipless Stone Basket...
Medicine Products: